Sinopharm sells 30.13% stake in Guorui Pharma to Shanghai Shyndec for RMB 240.07 millionPUBT·Aug 19, 2026 at 02:00 PM01099-0.42%000028-0.05%
Gaoxin Modern's 2025 annual equity distribution plan: a cash dividend of 0.2 yuan for every 10 shares同壁财经·May 25, 2026 at 11:26 AM600420-1.24%
SHYNDEC's holding subsidiary signs the "Drug Marketing Authorization Transfer Agreement"Zhitong·Nov 3, 2025 at 09:13 AM600420-1.24%
SHYNDEC: Famotidine injection has passed the consistency evaluation of quality and efficacy for generic drugsZhitong·Oct 17, 2025 at 11:29 AM600420-1.24%
The subsidiary of SHYNDEC, the raw material drug for sitagliptin phosphate, has received the approval notice for its listing applicationZhitong·Oct 10, 2025 at 09:30 AM600420-1.24%
SHYNDEC: SHYNDEC Rongsheng Vitamin B6 Injection increases specifications and passes consistency evaluationZhitong·Sep 22, 2025 at 08:59 AM600420-1.24%
SHYNDEC: Maleate Enalapril Tablets pass consistency evaluationZhitong·Sep 17, 2025 at 08:25 AM600420-1.24%
SHYNDEC: The hydrochloride of pentyl ether injection has obtained a drug registration certificateZhitong·Sep 16, 2025 at 08:56 AM600420-1.24%
SHYNDEC: Sodium Bicarbonate Injection increases specifications and passes the consistency evaluation of generic drugsZhitong·Sep 12, 2025 at 08:57 AM600420-1.24%
SHYNDEC: Wholly-owned subsidiary Guoyao Weiqida passed the drug GMP compliance inspectionZhitong·Sep 12, 2025 at 08:35 AM600420-1.24%
SHYNDEC's subsidiary obtains the registration certificate for injectable NicorandilZhitong·Sep 1, 2025 at 09:44 AM600420-1.24%
SHYNDEC: Net profit of 672 million yuan in the first half of 2025, a year-on-year decrease of 6.46%Zhitong·Aug 29, 2025 at 08:49 AM600420-1.24%
SHYNDEC's subsidiary has received approval for the listing application of hydrochloride ketamine raw materialsZhitong·Aug 7, 2025 at 08:26 AM600420-1.24%
SHYNDEC: The hydrochloride of perindopril tablets and calcium folinate injection have obtained drug registration certificatesZhitong·Jul 28, 2025 at 08:53 AM600420-1.24%
SHYNDEC's net profit attributable to the parent company in the first half of the year was 672 million yuan, a year-on-year decrease of 6.46%Zhitong·Jul 17, 2025 at 08:33 AM600420-1.24%
